Additionally, a meta-analysis of seven studies including 3437 DCIS cases showed that elevated TILs were associated with triple-negative and HER2+ phenotypes, higher grade, necrosis, and an increased risk of both invasive and non-invasive recurrence (48). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.